featured
featured Articles
Ally Financial has agreed to acquire non-prime credit card issuer and payment services company CardWorks for $2.65 billion in cash and stock. Ally's stock tanked on the news.
Published:
Argus downgraded Transocean fon Wednesday, in the wake of an earnings report that continued to show losses and concerns about challenging offshore drilling conditions, despite the company having a...
Published:
Karyopharm Therapeutics shares made a handy gain on Wednesday after the firm secured a key FDA nod for its relapsed or refractory diffuse large B-cell lymphoma treatment.
Published:
Groupon shares plunged early on Wednesday after the company announced its fourth-quarter earnings, along with a business update. Ultimately, investors did not view either of these as favorable.
Published:
Cosmetics and beauty products maker Coty is reportedly interested in selling its professional beauty brands. The sale could fetch as much as $8 billion according to some.
Published:
With even moderate appreciation in the share prices of these top companies, investors should be looking at double-digit total return potential. In a market that is very long in the tooth, that makes...
Published:
Walmart's new "Great Workplace" plan is expected to trigger job cuts that almost certainly will be in the thousands, another sign that brick-and-mortar retailers continue to struggle.
Published:
Bed Bath & Beyond has rolled out a new plan to improve its operating performance. But does it address the retailer's core problem?
Published:
When the value of a stock keeps rising over time, it tends to look and feel good for just about everyone involved. That said, sometimes things have become so rewarding that some companies decide to...
Published:
See why Argus believes that Teva Pharmaceutical has made progress concerning its challenges, which are already baked into the stock price.
Published:
Tesla stock continued to surge on Tuesday after a new report surfaced that the electric vehicle maker is looking to use cheaper Chinese lithium iron phosphate batteries in its vehicles.
Published:
Investors are not used to hearing is the word "biotech" used in the same sentence as anything to do with Warren Buffett and Berkshire Hathaway. Yet the portfolio managers have purchased shares of...
Published:
What is it like to have a stock plunge 90% in less than a year and wipe out a huge amount of shareholder value? That's what happened to Bio-Path.
Published:
Power company PG&E reported fourth-quarter and full-year results before markets opened Tuesday. The massive losses are less important than new threats to the bankruptcy settlement.
Published:
Agile Therapeutics shares took a dip on Tuesday after the company announced a key FDA approval for its new weekly contraceptive patch. Yet, one analyst sees great long-term potential, targeting the...
Published: